Results 61 to 70 of about 7,686 (224)

Laparoscopic gastroplasty for morbid obesity

open access: yesJournal of British Surgery, 1994
info:eu-repo/semantics ...
Cadière, Guy-Bernard   +3 more
openaire   +3 more sources

Obstructive Sleep Apnea Following Bariatric Surgery: 20 Year Outcomes From the Swedish Obese Subjects Study

open access: yesObesity, Volume 34, Issue 4, Page 819-828, April 2026.
ABSTRACT Objective Bariatric surgery has been suggested to improve obstructive sleep apnea (OSA) in short‐term studies, but long‐term evidence is limited. We evaluated remission and new onset of OSA over 20 years in participants from the Swedish Obese Subjects (SOS) study, comparing bariatric surgery with usual obesity care.
Ida Arnetorp   +8 more
wiley   +1 more source

Inspiratory loading exercises on respiratory muscle function in post-operative gastroplasty patients: a randomized clinical trial

open access: yesFisioterapia em Movimento, 2019
Introduction: The gastroplasty post-operative period can alter respiratory mechanics and predispose patients to respiratory complications. Objective: The objective was to evaluate the effects of exercises with inspiratory load on respiratory muscle ...
Maura Rigoldi Simões da Rocha   +5 more
doaj   +1 more source

Aspects of psychiatric care for obese patients under bariatric treatment: a review [PDF]

open access: yes, 2011
CONTEXTO: Nas últimas décadas, diversos estudos longitudinais têm demonstrado a eficácia da cirurgia bariátrica no controle de peso em longo prazo e na redução da mortalidade resultante de complicações clínicas associadas à obesidade. Contudo, os estudos
GORDON, Pedro C.   +2 more
core   +3 more sources

Gastroplasty for Respiratory Insufficiency of Obesity

open access: yesAnnals of Surgery, 1981
Three patients with the obesity hypoventilation syndrome and one patient with the sleep apnea syndrome underwent gastroplasty for weight reduction. A tracheostomy was also performed in the patient with sleep apnea. The PaO2 rose from an average of 51 +/- 9 to 71 +/- 5 torr and the PaCO2 fell from an average of 51 +/- 21 to 41 +/- 6 torr within two to ...
H J, Sugerman   +4 more
openaire   +3 more sources

Providing holistic care for patients with metabolic dysfunction‐associated steatotic liver disease/metabolic dysfunction‐associated steatohepatitis: Key aspects of clinical assessment and how to develop individualised care plans for surveillance and interventions

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue S2, Page 46-62, April 2026.
Abstract Metabolic dysfunction‐associated steatotic liver disease (MASLD), characterised by hepatic steatosis and metabolic dysfunction (i.e., obesity, type 2 diabetes, dyslipidaemia, and hypertension), is affecting over 30% of the adult population worldwide.
Lanlan Chen, Paul Horn, Frank Tacke
wiley   +1 more source

The Influence of Bariatric Surgery on Matrix Metalloproteinase Plasma Levels in Patients with Type 2 Diabetes Mellitus

open access: yesBiomolecules
Background: Bariatric surgery is a safe and effective procedure for treating obesity and metabolic conditions such as type 2 diabetes mellitus (T2DM).
João Kleber de Almeida Gentile   +3 more
doaj   +1 more source

Long-term survival of patients with stage IV hypopharyngeal cancer: Impact of fundus rotation gastroplasty [PDF]

open access: yes, 2018
Stage IV circular hypopharyngeal cancer is a disease with poor long-term survival, and the only means of cure—surgery—is associated with high morbidity.
Büchler, Markus   +5 more
core  

Digestive and metabolic changes in postoperative bariatric surgery [PDF]

open access: yes, 2010
RACIONAL: As alterações na digestão e perdas de nutrientes são aspectos relevantes na redução do peso e na manutenção do estado nutricional do paciente submetido à gastroplastia, mas poucos estudos estão disponíveis na literatura.
JACOB, Carlos Eduardo   +2 more
core   +3 more sources

Obesity and Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD): A Literature Review on Pathophysiology and Treatment

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue S2, Page 19-30, April 2026.
ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD) represents a key hepatic manifestation of obesity and systemic metabolic dysfunction and is a leading cause of chronic liver disease worldwide. Obesity‐driven mechanisms, including adipose tissue dysfunction, insulin resistance and increased free fatty acid flux to the liver ...
Michael Romanos   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy